1- Kuroda Y, Hara Y. Anitmutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res. 1999 Jan; 436: 69-97.

2- Katiyar, SK, Mukhtar, H. Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl 1997; 27: 59-67.

3- Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999 Nov; 125:589-97.

4- Eastwood MA. Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease. QJM 1999; 92: 527-30.

5- Pryor WA, Stahl W, Rock CL. Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000; 58: 39-53.

6- Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91: 2102-6.

7- Dawson MI. The importance of vitamin A in nutrition. Curr Pharm Des 2000; 6: 311-25.

8- Emmett DH, Kirchner JT. The role of vitamin E in the prevention of heart disease. Arch Fam Med 1999; 8: 537-42.

9- Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000: 28: 141-64.

10- Bunout D, Garrido A, Suazo M, Kauffman R, Venegas P, de la Maza P, Petermann M, Hirsch S. Effects of supplementation with folic acid on homocysteine levels and LDL oxidation in coronary patients. Nutrition 2000; 16: 107-10.

11- Evans JR, Henshaw K. Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration. Cochrane Database Syst Rev 2000; 2: CD000253.

12- Evans JR. Gingko biloba extract for age-related macular degeneration. Cochrane Database Syst Rev 2000; 2: CD001775.

13- Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-20.

14- Zaltzberg H, Kanter Y, Aviram M, Levy Y. Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. Isr Med Assoc J 1999; 1: 228-31.

15- Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, Cao P, Sies H, Senin U. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev 2000; 16: 15-9.

16- Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota A, Hiai H, Seino Y. Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes.

17- Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000; 71: 621S-629S.

18- Emilien G, Beyreuther K, Masters CL, Maloteaux JM. Prospects for pharmacologic intervention in Alzheimer disease. Arch Neurol 2000; 57: 454-9.

19- Pappolla MA, Chyan YJ, Poeggeler B, Bozner P, Ghiso J, LeDoux SP, Wilson GL. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res 1999; 27: 226-9.

20- Kiline A, Yalcin AS, Yalcin D, Taga Y, Emerk K. Increased erythrocyte susceptibility to lipid peroxidation in Parkinson's disease. Neurosci Lett 1988; 87: 307-10.

21- Ebadi M, Srinivasan SK, Baxi MD. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 1996; 48: 1-19.

22- Emmert DH, Kirchner JT. The role of vitamin E in the prevention of heart disease. Arch Fam Med 1999; 8: 537-42.

23- Leppala JM, Virtamo J, Fogelholm R, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000; 20: 230-5.

24- Moriguchi S, Muraga M. Vitamin E and immunity. Vitam Horm 2000; 59: 305-36.
25 Peskind ER. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. J Clin Psychiatry 1998; 59: 22-7.

26- Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota A, Hiai H, Seino Y. Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 2000; 473: 24-6.

27- Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999; 222: 196-204.

28- Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000; 18: 411-5.

29- Simon JA, Hudes ES. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults: the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 1999; 9: 358-65.

30- Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med 2000; 160: 931-6.

31- Giugliano D. Dietary antioxidants for cardiovascular protection. Nutr Metab Cardiovasc Dis 2000; 10: 38-44.

32- Pratt S. Dietary prevention of age-related macular degeneration. J Am Optom Assoc 1999; 70: 39-47.

33- Pryor WA, Stahl W, Rock CL. Beta carotene: from biochemistry to clinical trials. Nutr Rev 2000; 58: 39-53.

34- Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91: 2102-6.

35- Paiva SA, Russell RM. Beta-carotene and other carotenoids as antioxidants. J Am Cell Nutr 1999; 18: 426-33.

36- Thompson HJ, Meeker LD, Becci PJ. Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res 1981; 41L 1413-6.

37- Cann SA, van Netten JP, van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control 2000; 11: 121-7.

38- Lesourd BM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr 1997; 66L 478S-484S.

39- Mutlu-Turkoglu U, Erbil Y, Oztezcan S, Olgac V, Toker G, Uysal M. The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury. Life Sci 2000: 66: 1905-13.

40- Maulik N, Yoshida T, Engelman RM, Bagchi D, Otani H, Das DK. Dietary coenzyme Q(10) supplement renders swine hearts resistant to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2000; 278: H1084-90.

41- Khatta M, Alexander BS, Krichten CM, Fisher CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med 2000; 132: 636-40.

42- Chung JG. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat. Toxicol Sci 1999; 51: 202-10.

43- Qi W, Reiter RJ, Tan DX, Garcia JJ, Karbownik M, Manchester LC, Calvo JR. Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E. Environ Health Perspect 2000; 108: 399-402.

44- Ahlersova E, Ahlers I, Kubatka P, Bojkova B, Mocikova K, Gajdosova S, Onderkova HM. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats. Folia Bio, (Praha) 2000; 46: 69-72.

45- Lagneux C, Joyeux M, Demenge P, Ribuot C, Godin-Ribuot D. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000; 66: 503-9.

46- Lin JK, Liang YC. Cancer chemoprevention by tea polyphenols. Proc Natl Sci Counc Repub China B 2000; 24: 1-13.

47- Manuel y Keenoy B, Vertommen J, De Leeuw I. The effect of flavonoid treatment on the glycation and antioxidant status in Type I diabetic patients. Diabetes Nutr Metab 1999; 12: 256-63.

48- Ali AT, al-Swayeh OA, al-Humayyd MS, Mustafa AA, al-Rashad RS, al-Tuwaijiri AS. Natural honey prevents ischaemia-reperfusion-induced gastric mucosal lesions and increased vascular permeability in rats. Eur J Gastroenterol Hepatol 1997; 9: 1101-7.

49- Wahdan HA. Causes of the antimicrobial activity of honey. Infection 1998; 26: 26-31.